Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

This study has been completed.

Study NCT00315757 Information provided by Human Genome Sciences

First Received: April 17, 2006 Last Updated: April 11, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2010
Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: March 30, 2011